Delivery Order SPE2DR25D3010-SPE2DR26F88PF
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $7,258.92 by the Defense Logistics Agency (DLA) on January 13, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction. Performance will be completed at the awardee's location in Conshohocken, Pennsylvania, with an ultimate completion date of January 14,...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., received a delivery order award from the Defense Logistics Agency (DLA) on January 23, 2026, for Repatha 140 mg/ml SureClick auto-injectors, valued at $5,758.55. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 26, 2026. The place of performance is Conshohocken, Pennsylvania, where Amerisourcebergen maintains its corporate headquarters. This delivery...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for $72,275.29 to supply Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price contract is scheduled for completion by December 3, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The delivery order represents a child contract action under AmerisourceBergen's larger DLA Troop Support Medical Indefinite Delivery Contract (IDC),...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $61,117.01 by the Defense Logistics Agency on January 12, 2026, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The ultimate completion date is set for January 13, 2026. This delivery order is executed under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $2,971.95 firm fixed-price delivery order from the Defense Logistics Agency on January 15, 2026, for Repatha 140 mg/ml SureClick auto-injectors. The award is unset-aside and competitively awarded, with an ultimate completion date of January 16, 2026. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s comprehensive Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $88,386.24 on January 21, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price, non-set-aside contract is funded by the Defense Logistics Agency (DLA) and will be completed by January 22, 2026, with performance taking place at the contractor's Conshohocken facility. The award represents a task order under...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $16,340.28 by the Defense Logistics Agency on August 4, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract represents a firm fixed-price delivery order with no set-aside designation and is scheduled for completion by August 5, 2025. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $41,346.30 by the Defense Logistics Agency (DLA) on August 28, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price contract has an ultimate completion date of August 29, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order was issued with no set-aside designation, reflecting the open competition process...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on November 26, 2025, by the Defense Logistics Agency for the supply of Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price delivery order has a ceiling value of $3,750.79 and an ultimate completion date of November 28, 2025. The contract is not set-aside and represents a competitive award under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,349.17 by the Defense Logistics Agency on September 9, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract is not set-aside and was competitively awarded with a firm fixed price structure and an ultimate completion date of September 10, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DR25D3010Indefinite Delivery Contract
- SPE2DR25D3010-SPE2DR26F88PFDelivery Order
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $31,317.04 by the Defense Logistics Agency (DLA) on January 23, 2026, for the supply of Repatha 140 mg/mL SureClick auto-injector pharmaceutical product. The contract is firm fixed-price with no set-aside designation and is scheduled for completion by January 26, 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of medications and medical commodities to support military healthcare programs worldwide. AmerisourceBergen's substantial IDC with DLA reflects the company's critical role as a pharmaceutical prime vendor, supplying specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. As a major pharmaceutical distributor with extensive federal procurement experience, AmerisourceBergen has demonstrated consistent capability to meet government requirements through open competition, with this Repatha delivery order representing a routine procurement under the established prime vendor relationship.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.3k | 1/22/26 |